NO20044774L - Velsmakende tyggetablett - Google Patents

Velsmakende tyggetablett

Info

Publication number
NO20044774L
NO20044774L NO20044774A NO20044774A NO20044774L NO 20044774 L NO20044774 L NO 20044774L NO 20044774 A NO20044774 A NO 20044774A NO 20044774 A NO20044774 A NO 20044774A NO 20044774 L NO20044774 L NO 20044774L
Authority
NO
Norway
Prior art keywords
chewable tablet
tasty
tasty chewable
flavor additive
incorporating
Prior art date
Application number
NO20044774A
Other languages
English (en)
Norwegian (no)
Inventor
Kasra Kasraian
Tanya Havlir
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20044774L publication Critical patent/NO20044774L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20044774A 2002-04-04 2004-11-03 Velsmakende tyggetablett NO20044774L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37008602P 2002-04-04 2002-04-04
PCT/IB2003/001130 WO2003084511A1 (fr) 2002-04-04 2003-03-26 Tablette a macher sapide

Publications (1)

Publication Number Publication Date
NO20044774L true NO20044774L (no) 2004-11-03

Family

ID=28792024

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044774A NO20044774L (no) 2002-04-04 2004-11-03 Velsmakende tyggetablett

Country Status (23)

Country Link
US (1) US7482022B2 (fr)
EP (1) EP1494654B1 (fr)
JP (1) JP2005526104A (fr)
KR (1) KR20040098036A (fr)
CN (1) CN100335041C (fr)
AR (1) AR039242A1 (fr)
AT (1) ATE388693T1 (fr)
BR (1) BR0308927A (fr)
CA (1) CA2481025A1 (fr)
DE (1) DE60319685T2 (fr)
ES (1) ES2298540T3 (fr)
HN (1) HN2003000112A (fr)
IL (1) IL164106A0 (fr)
MX (1) MXPA04009617A (fr)
NO (1) NO20044774L (fr)
PA (1) PA8570601A1 (fr)
PE (1) PE20030950A1 (fr)
PL (1) PL372904A1 (fr)
RU (1) RU2004129573A (fr)
TW (1) TW200401651A (fr)
UY (1) UY27746A1 (fr)
WO (1) WO2003084511A1 (fr)
ZA (1) ZA200407537B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE486587T1 (de) * 2002-01-15 2010-11-15 Ucb Farchim Sa Formulierungen zur oralen verabreichung von wirkstoffen
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20080113944A1 (en) 2004-05-04 2008-05-15 Novo Nordisk A/S Novel Indole Derivatives
ATE464883T1 (de) * 2004-07-22 2010-05-15 Bend Res Inc Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20090269393A1 (en) * 2006-06-12 2009-10-29 Jubliant Organosys Limited Chewable Bilayer Tablet Formulation
DK2178521T3 (da) * 2007-07-11 2014-04-28 Fertin Pharma As Stabilt medicinsk tyggegummi omfattende cyclodextrin-inklusionskompleks
WO2009006892A1 (fr) * 2007-07-11 2009-01-15 Fertin Pharma A/S Gomme à mâcher médicamenteuse stable comprenant un antioxydant
WO2009006899A1 (fr) * 2007-07-11 2009-01-15 Fertin Pharma A/S Tablette de gomme à mâcher comprimée comprenant un agent masquant le goût
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
DK2498758T3 (en) 2009-11-13 2018-10-15 Astrazeneca Ab TWO-LAYER TABLET FORMULATIONS
WO2011110939A2 (fr) 2010-03-11 2011-09-15 Rubicon Research Private Limited Compositions pharmaceutiques de benzhydrylpipérazines substituées
JPWO2013129436A1 (ja) * 2012-02-29 2015-07-30 武田薬品工業株式会社 経口剤
PT2861236T (pt) 2012-06-15 2019-10-28 Pharmathen Sa Composição farmacêutica contendo polímero de ligação a fosfato
CN102716099B (zh) * 2012-07-05 2013-10-09 湖南千金湘江药业股份有限公司 盐酸左西替利嗪咀嚼片及其制备方法
JP6280554B2 (ja) 2012-09-28 2018-02-14 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Ｅｒｋ阻害剤である新規化合物
WO2016033424A1 (fr) 2014-08-29 2016-03-03 Genzyme Corporation Méthodes de prévention et de traitement d'évènements indésirables cardiovasculaires majeurs à l'aide de composés modulant l'apolipoprotéine b
JP2016094364A (ja) * 2014-11-14 2016-05-26 ニプロ株式会社 安定化および苦味抑制された口腔内崩壊製剤
EP3061501A1 (fr) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition pour le traitement de l'acné
EP3117825A1 (fr) 2015-07-16 2017-01-18 Rottapharm S.p.A. Formulation orale comprenant de la berbérine et un extrait de morus alba
JP2019001730A (ja) * 2017-06-13 2019-01-10 武田テバファーマ株式会社 安定な経口医薬組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558600A (en) 1967-07-28 1971-01-26 Abbott Lab Alkyl sulfate salts of 1-(p-chlorobenzhydryl)-4-methylhomopiperazines
NO155805C (no) 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US4650663A (en) 1983-07-20 1987-03-17 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antitussives
US4792448A (en) 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
ES2067957T3 (es) 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
AU678561B2 (en) 1992-10-09 1997-06-05 Procter & Gamble Company, The Pharmaceutical compositions and methods for treating cold symptoms
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6270790B1 (en) 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
ATE486587T1 (de) * 2002-01-15 2010-11-15 Ucb Farchim Sa Formulierungen zur oralen verabreichung von wirkstoffen

Also Published As

Publication number Publication date
RU2004129573A (ru) 2005-04-10
WO2003084511A1 (fr) 2003-10-16
CN1642531A (zh) 2005-07-20
ATE388693T1 (de) 2008-03-15
JP2005526104A (ja) 2005-09-02
CN100335041C (zh) 2007-09-05
DE60319685T2 (de) 2009-03-26
EP1494654A1 (fr) 2005-01-12
KR20040098036A (ko) 2004-11-18
DE60319685D1 (de) 2008-04-24
AU2003209953A1 (en) 2003-10-20
US7482022B2 (en) 2009-01-27
ES2298540T3 (es) 2008-05-16
AR039242A1 (es) 2005-02-16
CA2481025A1 (fr) 2003-10-16
EP1494654B1 (fr) 2008-03-12
TW200401651A (en) 2004-02-01
PL372904A1 (en) 2005-08-08
PA8570601A1 (es) 2003-12-10
BR0308927A (pt) 2005-01-04
ZA200407537B (en) 2006-06-28
PE20030950A1 (es) 2003-11-12
US20030215503A1 (en) 2003-11-20
HN2003000112A (es) 2004-05-05
IL164106A0 (en) 2005-12-18
MXPA04009617A (es) 2005-01-11
UY27746A1 (es) 2003-10-31

Similar Documents

Publication Publication Date Title
NO20044774L (no) Velsmakende tyggetablett
DE60325354D1 (de) Topisch anwendbare pharmazeutische zubereitung
YU58103A (sh) Farmaceutski preparati, dozirane forme i postupci za oralnu primenu epotilona
NO20044866L (no) Pyrazolo-pyrimidin-anilin-forbindelser anvendelige som kinase-inhibitorer
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
NO20065904L (no) Terapeutiske forbindelser
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
MXPA03001431A (es) Polimeros de un analogo de epotilona.
WO2004037222A3 (fr) Preparations de tramadol a liberation soutenue dotees d'une efficacite de 24 heures
TW200626598A (en) Pyrrazolo-pyrimidine derivatives
WO2001072728A3 (fr) Nouveaux derives de piperazine
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
NO20044452L (no) Oral administrering av epotiloner
RS52233B (en) THE PHARMACEUTICAL DOSAGE FORM CONTAINING GRANULES AND ITS PRODUCTION PROCEDURE
NO20073830L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
WO2002088100A3 (fr) 3-piperidinopropiophenones dopees et produits pharmaceutiques contenant ces composes
RS51146B (sr) Novi difenil-azetidinon sa poboljšanim fiziološkim osobinama postupak za njegovu proizvodnju,lekovi koji sadrže ovo jedinjenje i njihova upotreba
CA2428160A1 (fr) Compositions contenant de l'ecteinascidine 743 pour traitement antitumoral
NO20013409L (no) Anvendelse av pyrimidin-derivater for forhindring og behandling av cerebral ischemi
AU2001276889A1 (en) Preventing airway mucus production by administration of egf-r antagonists
HK1068003A1 (en) Pharmaceutical composition comprising gamma-butyrobetaine
ATE410152T1 (de) Therapeutisches system mit amoxicillin und clavulansäure
MXPA02012029A (es) Kit para reducir dolor continuo.
WO2005051349A3 (fr) Compositions pharmaceutiques de mirtazapine
WO2004037844A8 (fr) Gamma-lactone de l'acide carboxylique 17beta-hydroxy-7alpha-(5'-methyl-2'-furyl)-pregna-4,9(11)-diene-3-one-21